Neutra (NTRR) 10-Q/A 18 Sep 18 2019 Q2 Quarterly report (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jul. 31, 2018	Sep. 13, 2018
Document And Entity Information
Entity Registrant Name	NEUTRA CORP.
Entity Central Index Key	1,512,886
Document Type	10-Q
Trading Symbol	NTRR
Document Period End Date	Jul. 31, 2018
Amendment Flag	false
Current Fiscal Year End Date	--01-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filer	No
Entity Reporting Status Current	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		7,182,983
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2,019

CONSOLIDATED BALANCE SHEETS (UN

CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Jul. 31, 2018	Jan. 31, 2018
CURRENT ASSETS
Deposits	$ 30,630	$ 12,325
Total current assets	30,630	12,325
TOTAL ASSETS	30,630	12,325
CURRENT LIABILITIES
Accounts payable and accrued expenses	458,480	458,480
Accounts payable to related party	83,692	83,692
Advances payable	3,450	3,450
Current portion of convertible notes payable, in default	181,843	141,843
Current portion of convertible notes payable, net of discount of $306,152 and $224,861, respectively	83,559	4,865
Current portion of accrued interest payable	92,985	55,343
Total current liabilities	904,009	747,673
Convertible notes payable, net of discount of $0 and $50,800, respectively		17,185
Accrued interest payable		11,939
TOTAL LIABILITIES	904,009	776,797
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT
Common stock, $0.001 par value; 480,000,000 shares authorized; 7,182,983 and 6,839,274 shares issued and outstanding at July 31, 2018 and January 31, 2018, respectively	7,183	6,839
Series E preferred stock, $0.001 par value; 20,000,000 shares authorized; 1,000,000 shares issued or outstanding at July 31, 2018 and January 31, 2018, respectively	1,000	1,000
Additional paid-in capital	5,822,971	5,661,911
Accumulated deficit	(6,704,533)	(6,434,222)
Total stockholders' deficit	(873,379)	(764,472)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 30,630	$ 12,325

CONSOLIDATED BALANCE SHEETS (U3

CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)	Jul. 31, 2018	Jan. 31, 2018
Statement of Financial Position [Abstract]
Current portion of convertible notes payable, discount	$ 306,152	$ 224,861
Convertible notes payable, discount	$ 0	$ 50,800
Common Stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common Stock, authorized	480,000,000	480,000,000
Common Stock, issued	7,182,983	6,839,274
Common Stock, outstanding	7,182,983	6,839,274
Series E preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series E preferred stock, authorized	20,000,000	20,000,000
Series E preferred stock, issued	1,000,000	1,000,000
Series E preferred stock, outstanding	1,000,000	1,000,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
Income Statement [Abstract]
REVENUE			$ 2,006
OPERATING EXPENSES
General and administrative	62,349	34,539	126,201	90,443
LOSS FROM OPERATIONS	(62,349)	(34,539)	(124,195)	(90,443)
OTHER INCOME (EXPENSE)
Interest expense	(76,118)	(119,590)	(146,116)	(273,698)
Total other income (expense)	(76,118)	(119,590)	(146,116)	(273,698)
NET LOSS	$ (138,467)	$ (154,129)	$ (270,311)	$ (364,141)
NET LOSS PER COMMON SHARE - Basic and fully diluted (in dollars per share)	$ (0.02)	$ (0.03)	$ (0.04)	$ (0.09)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Basic and fully diluted (in shares)	7,182,983	4,843,317	7,021,573	4,222,302

CONSOLIDATED STATEMENT OF STOCK

CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - 6 months ended Jul. 31, 2018 - USD ($)	Common Stock [Member]	Series E Preferred Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
BALANCE, beginning at Jan. 31, 2018	$ 6,839	$ 1,000	$ 5,661,911	$ (6,434,222)	$ (764,472)
BALANCE, beginning (in shares) at Jan. 31, 2018	6,839,274	1,000,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for debt conversion	$ 344		18,560		18,904
Common stock issued for debt conversion (in shares)	343,709
Beneficial conversion discount on issuance of convertible note payable			142,500		142,500
Net loss				(270,311)	(270,311)
BALANCE, end at Jul. 31, 2018	$ 7,183	$ 1,000	$ 5,822,971	$ (6,704,533)	$ (873,379)
BALANCE, end (in shares) at Jul. 31, 2018	7,182,983	1,000,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
CASH FLOW FROM OPERATING ACTIVITIES:
Net Loss	$ (270,311)	$ (364,141)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount on convertible note payable	119,509	251,185
Changes in operating assets and liabilities:
Deposits	(18,305)	(10,293)
Accounts payable and accrued liabilities		(52,605)
Accounts payable to related party		38,892
Accrued interest payable	26,607	22,513
NET CASH USED IN OPERATING ACTIVITIES	(142,500)	(114,449)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	142,500	114,449
NET CASH PROVIDED BY FINANCING ACTIVITIES	142,500	114,449
NET INCREASE (DECREASE) IN CASH
CASH, at the beginning of the period
CASH, at the end of the period
Cash paid during the period for:
Interest
Taxes
Noncash investing and financing transaction:
Beneficial conversion discount on convertible note payable	142,500	108,926
Conversion of convertible notes payable.	$ 18,904	$ 211,615

General Organization and Busine

General Organization and Business	6 Months Ended
	Jul. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General Organization and Business	Note 1. General Organization and Business Neutra Corp. was incorporated in Nevada on January 11, 2011 to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, we plan to research and bring new technology to the nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body’s vital ability to heal and maintain itself. One of the nutraceutical sub-markets is the new thriving medical cannabis market, in which we intend to participate. We intend to entrust the manufacturing to a nutraceutical contractor to private label all of our products and to sell them under our unique brand. We have established a fiscal year end of January 31. As the global cannabis market grows exponentially, it is constantly in need of better technologies and products to be more efficient in how it grows, what it grows and how it consumes cannabis and its related products. From lighting to dosage devices, from pesticide replacements to plant enhancers, Neutra Corp. is constantly combing the industry for the latest and greatest to test, prove and bring to market. We have not generated any revenues to date and our activities have been limited to developing our business plan and research and development of products. We will not have the necessary capital to fully develop or execute our business plan until we are able to secure additional financing. There can be no assurance that such financing will be available on suitable terms. We need to raise additional funds in order to implement our business plan. Our current cash on hand is insufficient to commercialize our products or fully develop our business strategy. If we are unable to raise adequate additional funds or if those funds are not available on terms that are acceptable to us, we will not be able to execute our business plan and we may cease operations.

Going Concern

Going Concern	6 Months Ended
	Jul. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Note 2. Going Concern The accompanying financial statements have been prepared assuming that we will continue as a going concern. For the six months ended July 31, 2018, we had a net loss of $270,311 and negative cash flow from operating activities of $142,500. As of July 31, 2018, we had negative working capital of $873,379. Management does not anticipate having positive cash flow from operations in the near future. These factors raise a substantial doubt about our ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. We do not have the resources at this time to repay its credit and debt obligations, make any payments in the form of dividends to its shareholders or fully implement its business plan. Without additional capital, the we will not be able to remain in business. Management has plans to address the Company’s financial situation as follows: In the near term, management plans to continue to focus on raising the funds necessary to implement our business plan. Management will continue to seek out debt financing to obtain the capital required to meet our financial obligations. There is no assurance, however, that lenders will continue to advance capital to us or that the new business operations will be profitable. The possibility of failure in obtaining additional funding and the potential inability to achieve profitability raise doubts about our ability to continue as a going concern. In the long term, management believes that our projects and initiatives will be successful and will provide cash flow, which will be used to finance our future growth. However, there can be no assurances that our planned activities will be successful, or that we will ultimately attain profitability. Our long-term viability depends on its ability to obtain adequate sources of debt or equity funding to meet current commitments and fund the continuation of its business operations, and our ability to achieve adequate profitability and cash flows from operations to sustain its operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 31, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3. Summary of Significant Accounting Policies Interim Financial Statements The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2018 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”). The results of operations for the six-month period ended July 31, 2018 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2019. Consolidated Financial Statements The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries from the date of their formations. Significant intercompany transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Earnings (Loss) per Common Share We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share Recently Issued Accounting Pronouncements We have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

Related Party Transactions

Related Party Transactions	6 Months Ended
	Jul. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions	Note 4. Related Party Transactions During the six months ended July 31, 2018, we incurred salary expense of $54,500 related to services provided by our CEO Christopher Brown. We paid Mr. Brown $54,500 in salary during the six months ended July 31, 2018. As of July 31, 2018, we owe Mr. Brown $89,200, which is recorded on the balance sheet in “Accounts Payable - Related Party.”

Advances

Advances	6 Months Ended
	Jul. 31, 2018
Debt Disclosure [Abstract]
Advances	Note 5. Advances As of July 31, 2018 and January 31, 2018, we had amounts due under advances of $3,450 at each period. These advances are not collateralized, non-interest bearing and are due on demand.

Convertible Notes Payable

Convertible Notes Payable	6 Months Ended
	Jul. 31, 2018
Debt Disclosure [Abstract]
Convertible Notes Payable	Note 6. Convertible Notes Payable Convertible notes payable consists of the following as of July 31, 2018 and January 31, 2018: July 31, 2018 January 31, 2018 Convertible note, dated July 31, 2015, bearing interest at 10% per annum, maturing on July 31, 2017 and convertible into shares of common stock at $0.01 per share, in default 72,640 72,640 Convertible note, dated October 31, 2015, bearing interest at 10% per annum, maturing on October 31, 2018 and convertible into shares of common stock at $0.50 per share 156,976 156,976 Convertible note, dated January 31, 2016, bearing interest at 10% per annum, maturing on January 31, 2019 and convertible into shares of common stock at a 60% discount to the market price 82,735 82,735 Convertible note, dated March 14, 2016, bearing interest at 8% per annum, maturing on March 14, 2017, and convertible into shares of common stock at a4 5% discount to the market price, in default 1,217 1,217 Convertible note, dated May 26, 2016, bearing interest at 8% per annum, maturing on May 26, 2017, and convertible into shares of common stock at a 45% discount to the market price, in default 67,986 67,986 Convertible note, dated September 6, 2016, bearing interest at 8% per annum, maturing September 6, 2017, and convertible into shares of common stock at a 45% discount to the lowest trading price in the 20 days prior to conversion with a floor on the conversion price of $0.00005 — 18,000 Convertible note, dated September 6, 2016, bearing interest at 8% per annum, maturing September 6, 2017, and convertible into shares of common stock at a 45% discount to the lowest trading price in the 20 days prior to conversion with a floor on the conversion price of $0.00005, in default 40,000 40,000 Convertible note, dated February 6, 2018, bearing interest at 8% per annum, maturing November 6, 2018, and convertible into shares of common stock at a 45% discount to the lowest trading price in the 20 days prior to conversion with a floor on the conversion price of $0.00005 150,000 — Total convertible notes payable $ 571,554 $ 439,554 Less: current portion of convertible notes payable (571,554 ) (371,569 ) Less: discount on noncurrent convertible notes payable — (50,800 ) Convertible notes payable - non-current, net of discount $ — $ 17,185 Current portion of convertible notes payable $ 571,554 $ 371,569 Less: discount on current convertible notes payable (306,152 ) (224,861 ) Convertible notes payable, net of discount $ 265,402 $ 146,708 Issuance of Convertible Promissory Notes During the six months ended July 31, 2018 and 2017, we issued Convertible Promissory Notes. The Convertible Promissory Notes bear interest and are payable at maturity along with accrued interest. The Convertible Promissory Notes and unpaid accrued interest are convertible into common stock at the option of the holder. Date Issued Maturity Date Interest Rate Conversion Rate Amount of Note February 6, 2018 November 6, 2018 8% 45% discount $ 150,000 Date Issued Maturity Date Interest Rate Conversion Rate Amount of Note March 14, 2016 March 14, 2017 8% 55% discount $ 65,000 April 30, 2016 April 30, 2019 10% 60% discount 67,986 We evaluated the terms of the new notes in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock Convertible Promissory Notes Issued for Cash On February 6, 2018, we issued a convertible promissory note to a third party for cash. The note (the “front-end note”) was in the amount of $150,000, and it matures on November 6, 2018. The note bears interest at 8% per year and is convertible into shares of our common stock at a 45% discount to our lowest trading price over the preceding 20 days with a floor on the conversion price of $0.00005. We evaluated the terms of the note in accordance with ASC Topic No. 815 - 40, Derivatives and Hedging - Contracts in Entity’s Own Stock Conversions to Common Stock During six months ended July 31, 2017, the holders of our convertible promissory notes converted $211,615 of principal and accrued interest into 2,904,086 shares of our common stock. See Note 7. No gain or loss was recognized on the conversions as they occurred within the terms of the agreement which provided for conversion. During six months ended July 31, 2018, the holders of our convertible promissory notes converted $18,904 of principal and accrued interest into 343,709 shares of our common stock. See Note 7. No gain or loss was recognized on the conversions as they occurred within the terms of the agreement which provided for conversion.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jul. 31, 2018
STOCKHOLDERS' DEFICIT
Stockholders' Equity	Note 7. Stockholders’ Equity Conversions to common stock During six months ended July 31, 2018, the holders of our convertible notes elected to convert principal and interest into shares of common stock as detailed below: Date Amount Converted Number of Shares Issued April 26, 2018 $ 18,904 373,709 Total $ 18,904 373,709 During six months ended July 31, 2017, the holders of our convertible notes elected to convert principal and interest into shares of common stock as detailed below: Date Amount Converted Number of Shares Issued February 13, 2017 $ 16,619 151,085 February 22, 2017 25,066 227,870 March 6, 2017 23,629 214,807 March 21, 2017 12,784 102,168 March 30, 2017 21,346 170,595 April 7, 2017 10,690 92,558 April 20, 2017 35,372 321,567 May 22, 2017 10,055 130,582 May 30, 2017 650 65,000 June 2, 2017 10,079 160,748 June 2, 2017 650 65,000 June 13, 2017 11,113 202,060 June 30, 2017 10,140 290,344 July 12, 2017 10,167 308,078 July 25, 2017 13,255 401,624 Total $ 211,615 2,904,086

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	Note 8. Subsequent Events No events have occurred subsequent to July 31, 2018 which would require disclosure in these financial statements.

Summary of Significant Accoun15

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 31, 2018
Accounting Policies [Abstract]
Interim Financial Statements	Interim Financial Statements The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the fiscal year ended January 31, 2018 and notes thereto and other pertinent information contained in our Form 10-K that we filed with the Securities and Exchange Commission (the “SEC”). The results of operations for the six-month period ended July 31, 2018 are not necessarily indicative of the results to be expected for the full fiscal year ending January 31, 2019.
Consolidated Financial Statements	Consolidated Financial Statements The consolidated financial statements of the Company include the accounts of the Company and its wholly owned subsidiaries from the date of their formations. Significant intercompany transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Earnings (Loss) per Common Share	Earnings (Loss) per Common Share We compute basic and diluted earnings per common share amounts in accordance with ASC Topic 260, Earnings per Share
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements We have reviewed the FASB issued Accounting Standards Update (“ASU”) accounting pronouncements and interpretations thereof that have effectiveness dates during the periods reported and in future periods. We have carefully considered the new pronouncements that alter previous generally accepted accounting principles and does not believe that any new or modified principles will have a material impact on the corporation’s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of our financial management and certain standards are under consideration.

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	6 Months Ended
	Jul. 31, 2018
Debt Disclosure [Abstract]
Schedule of convertible notes payable	Convertible notes payable consists of the following as of July 31, 2018 and January 31, 2018: July 31, 2018 January 31, 2018 Convertible note, dated July 31, 2015, bearing interest at 10% per annum, maturing on July 31, 2017 and convertible into shares of common stock at $0.01 per share, in default 72,640 72,640 Convertible note, dated October 31, 2015, bearing interest at 10% per annum, maturing on October 31, 2018 and convertible into shares of common stock at $0.50 per share 156,976 156,976 Convertible note, dated January 31, 2016, bearing interest at 10% per annum, maturing on January 31, 2019 and convertible into shares of common stock at a 60% discount to the market price 82,735 82,735 Convertible note, dated March 14, 2016, bearing interest at 8% per annum, maturing on March 14, 2017, and convertible into shares of common stock at a4 5% discount to the market price, in default 1,217 1,217 Convertible note, dated May 26, 2016, bearing interest at 8% per annum, maturing on May 26, 2017, and convertible into shares of common stock at a 45% discount to the market price, in default 67,986 67,986 Convertible note, dated September 6, 2016, bearing interest at 8% per annum, maturing September 6, 2017, and convertible into shares of common stock at a 45% discount to the lowest trading price in the 20 days prior to conversion with a floor on the conversion price of $0.00005 — 18,000 Convertible note, dated September 6, 2016, bearing interest at 8% per annum, maturing September 6, 2017, and convertible into shares of common stock at a 45% discount to the lowest trading price in the 20 days prior to conversion with a floor on the conversion price of $0.00005, in default 40,000 40,000 Convertible note, dated February 6, 2018, bearing interest at 8% per annum, maturing November 6, 2018, and convertible into shares of common stock at a 45% discount to the lowest trading price in the 20 days prior to conversion with a floor on the conversion price of $0.00005 150,000 — Total convertible notes payable $ 571,554 $ 439,554 Less: current portion of convertible notes payable (571,554 ) (371,569 ) Less: discount on noncurrent convertible notes payable — (50,800 ) Convertible notes payable - non-current, net of discount $ — $ 17,185 Current portion of convertible notes payable $ 571,554 $ 371,569 Less: discount on current convertible notes payable (306,152 ) (224,861 ) Convertible notes payable, net of discount $ 265,402 $ 146,708
Schedule of convertible promissory notes and unpaid accrued interest	The Convertible Promissory Notes and unpaid accrued interest are convertible into common stock at the option of the holder. Date Issued Maturity Date Interest Rate Conversion Rate Amount of Note February 6, 2018 November 6, 2018 8% 45% discount $ 150,000 Date Issued Maturity Date Interest Rate Conversion Rate Amount of Note March 14, 2016 March 14, 2017 8% 55% discount $ 65,000 April 30, 2016 April 30, 2019 10% 60% discount 67,986

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jul. 31, 2018
STOCKHOLDERS' DEFICIT
Schedule of conversions to common stock	During six months ended July 31, 2018, the holders of our convertible notes elected to convert principal and interest into shares of common stock as detailed below: Date Amount Converted Number of Shares Issued April 26, 2018 $ 18,904 373,709 Total $ 18,904 373,709 During six months ended July 31, 2017, the holders of our convertible notes elected to convert principal and interest into shares of common stock as detailed below: Date Amount Converted Number of Shares Issued February 13, 2017 $ 16,619 151,085 February 22, 2017 25,066 227,870 March 6, 2017 23,629 214,807 March 21, 2017 12,784 102,168 March 30, 2017 21,346 170,595 April 7, 2017 10,690 92,558 April 20, 2017 35,372 321,567 May 22, 2017 10,055 130,582 May 30, 2017 650 65,000 June 2, 2017 10,079 160,748 June 2, 2017 650 65,000 June 13, 2017 11,113 202,060 June 30, 2017 10,140 290,344 July 12, 2017 10,167 308,078 July 25, 2017 13,255 401,624 Total $ 211,615 2,904,086

Going Concern (Details Narrativ

Going Concern (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ (138,467)	$ (154,129)	$ (270,311)	$ (364,141)
Cash flow from operating activities			(142,500)	$ (114,449)
Working capital			$ 873,379

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	6 Months Ended
	Jul. 31, 2018	Jan. 31, 2018
Salary expense	$ 54,500
Accounts payable, related party	83,692	$ 83,692
Mr. Christopher Brown [Member]
Salary expense	54,500
Accounts payable, related party	$ 89,200

Advances (Details Narrative)

Advances (Details Narrative) - USD ($)	Jul. 31, 2018	Jan. 31, 2018
Advances payable	$ 3,450	$ 3,450
Non-Interest Bearing Advances [Member]
Advances payable	$ 3,450	$ 3,450

Convertible Notes Payable (Deta

Convertible Notes Payable (Details) - USD ($)	6 Months Ended		12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jan. 31, 2018	Feb. 06, 2018
Less: current portion of convertible notes payable	$ (83,559)		$ (4,865)
Less: discount on noncurrent convertible notes payable	0		(50,800)
Convertible notes payable, net of discount			17,185
Less: current portion of convertible notes payable	83,559		4,865
Less: discount on current convertible notes payable	(306,152)		(224,861)
10% Convertible Note Due October 31, 2018 [Member]
Total convertible notes payable	$ 156,976		$ 156,976
Debt instrument, issuance date	Oct. 31, 2015		Oct. 31, 2015
Debt instrument, conversion price (in dollars per share)	$ 0.50		$ 0.50
10% Convertible Note Due January 31, 2019 [Member]
Total convertible notes payable	$ 82,735		$ 82,735
Debt instrument, issuance date	Jan. 31, 2016		Jan. 31, 2016
8% Convertible Note Due March 14, 2017 [Member]
Total convertible notes payable	$ 1,217		$ 1,217
Debt instrument, issuance date	Mar. 14, 2016		Mar. 14, 2016
8% Convertible Note Due May 26, 2017 [Member]
Total convertible notes payable	$ 67,986		$ 67,986
Debt instrument, issuance date	May 26, 2016		May 26, 2016
8% Convertible Note Due September 06, 2017 [Member]
Total convertible notes payable	$ 40,000		$ 40,000
Debt instrument, issuance date	Sep. 6, 2016		Sep. 6, 2016
Debt instrument, conversion price (in dollars per share)	$ 0.00005		$ 0.00005
8% Convertible Note Due November 6, 2018 [Member]
Total convertible notes payable	$ 150,000			$ 150,000
Debt instrument, issuance date	Feb. 6, 2018
Debt instrument, conversion price (in dollars per share)	$ 0.00005			$ 0.00005
10% Convertible Note Due July 31, 2017 [Member]
Total convertible notes payable	$ 72,640		$ 72,640
Debt instrument, issuance date	Jul. 31, 2015		Jul. 31, 2015
Debt instrument, conversion price (in dollars per share)	$ 0.01		$ 0.01
10% Convertible Note Due April 30, 2019 [Member]
Total convertible notes payable		$ 67,986
Debt instrument, issuance date		Apr. 30, 2016
8% Convertible Note Due March 14, 2017 [Member]
Total convertible notes payable		$ 65,000
Debt instrument, issuance date		Mar. 14, 2016
8% Convertible Note Due September 6, 2017 [Member]
Total convertible notes payable			$ 18,000
Debt instrument, issuance date			Sep. 6, 2016
Convertible Notes Payable [Member]
Total convertible notes payable	$ 571,554		$ 439,554
Less: current portion of convertible notes payable	(571,554)		(371,569)
Less: discount on noncurrent convertible notes payable			(50,800)
Convertible notes payable, net of discount			17,185
Less: current portion of convertible notes payable	571,554		371,569
Less: discount on current convertible notes payable	(306,152)		(224,861)
Convertible notes payable, net of discount	$ 265,402		$ 146,708

Convertible Notes Payable (De22

Convertible Notes Payable (Details 1) - USD ($)	6 Months Ended		12 Months Ended
	Jul. 31, 2018	Jul. 31, 2017	Jan. 31, 2018	Feb. 06, 2018
10% Convertible Note Due October 31, 2018 [Member]
Date Issued/Funded	Oct. 31, 2015		Oct. 31, 2015
Total convertible notes payable	$ 156,976		$ 156,976
10% Convertible Note Due January 31, 2019 [Member]
Date Issued/Funded	Jan. 31, 2016		Jan. 31, 2016
Total convertible notes payable	$ 82,735		$ 82,735
8% Convertible Note Due March 14, 2017 [Member]
Date Issued/Funded	Mar. 14, 2016		Mar. 14, 2016
Total convertible notes payable	$ 1,217		$ 1,217
8% Convertible Note Due May 26, 2017 [Member]
Date Issued/Funded	May 26, 2016		May 26, 2016
Total convertible notes payable	$ 67,986		$ 67,986
8% Convertible Note Due September 06, 2017 [Member]
Date Issued/Funded	Sep. 6, 2016		Sep. 6, 2016
Total convertible notes payable	$ 40,000		$ 40,000
8% Convertible Note Due November 6, 2018 [Member]
Date Issued/Funded	Feb. 6, 2018
Total convertible notes payable	$ 150,000			$ 150,000
10% Convertible Note Due July 31, 2017 [Member]
Date Issued/Funded	Jul. 31, 2015		Jul. 31, 2015
Total convertible notes payable	$ 72,640		$ 72,640
10% Convertible Note Due April 30, 2019 [Member]
Date Issued/Funded		Apr. 30, 2016
Total convertible notes payable		$ 67,986
8% Convertible Note Due March 14, 2017 [Member]
Date Issued/Funded		Mar. 14, 2016
Total convertible notes payable		$ 65,000
8% Convertible Note Due September 6, 2017 [Member]
Date Issued/Funded			Sep. 6, 2016
Total convertible notes payable			$ 18,000
Convertible Notes Payable [Member]
Total convertible notes payable	$ 571,554		$ 439,554

Convertible Notes Payable (De23

Convertible Notes Payable (Details Narrative) - USD ($)	Feb. 06, 2018	Jan. 31, 2018	Jan. 31, 2017	Jul. 31, 2018	Jul. 31, 2017
Amortization of discount		$ 56,808	$ 143,413	$ 119,509	$ 251,185
Discount on issuance of convertible note payable				$ 142,500
Debt amount converted					$ 211,615
Number of common shares issued upon conversion of debt					2,904,086
8% Convertible Note Due November 6, 2018 [Member]
Principal value	$ 150,000
Conversion price (in dollars per shares)	$ 0.00005			$ 0.00005
Discount on issuance of convertible note payable	$ 142,500
Convertible Notes Payable [Member]
Debt amount converted				$ 18,904	$ 211,615
Number of common shares issued upon conversion of debt				343,709	2,904,086
10% Convertible Note Due July 31, 2017 [Member]
Conversion price (in dollars per shares)		$ 0.01		$ 0.01
10% Convertible Note Due October 31, 2018 [Member]
Conversion price (in dollars per shares)		0.50		0.50
8% Convertible Note Due September 06, 2017 [Member]
Conversion price (in dollars per shares)		$ 0.00005		$ 0.00005
April 26, 2018 [Member] | Convertible Notes Payable [Member]
Debt amount converted				$ 18,904
Number of common shares issued upon conversion of debt				343,709
April 7, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 10,690
Number of common shares issued upon conversion of debt					92,558
April 20, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 35,372
Number of common shares issued upon conversion of debt					321,567
February 13, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 16,619
Number of common shares issued upon conversion of debt					151,085
February 22, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 25,066
Number of common shares issued upon conversion of debt					227,870
March 6, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 23,629
Number of common shares issued upon conversion of debt					214,807
March 21, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 12,784
Number of common shares issued upon conversion of debt					102,168
March 30, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted					$ 21,346
Number of common shares issued upon conversion of debt					170,595

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	6 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Debt amount converted		$ 211,615
Number of shares issued upon conversion of debt		2,904,086
Convertible Notes Payable [Member]
Debt amount converted	$ 18,904	$ 211,615
Number of shares issued upon conversion of debt	343,709	2,904,086
February 13, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 16,619
Number of shares issued upon conversion of debt		151,085
February 22, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 25,066
Number of shares issued upon conversion of debt		227,870
March 6, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 23,629
Number of shares issued upon conversion of debt		214,807
May 22, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 10,055
Number of shares issued upon conversion of debt		130,582
May 30, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 650
Number of shares issued upon conversion of debt		65,000
June 2, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 10,079
Number of shares issued upon conversion of debt		160,748
June 2, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 650
Number of shares issued upon conversion of debt		65,000
June 13, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 11,113
Number of shares issued upon conversion of debt		202,060
June 30, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 10,140
Number of shares issued upon conversion of debt		290,344
July 12, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 10,167
Number of shares issued upon conversion of debt		308,078
July 25, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 13,255
Number of shares issued upon conversion of debt		401,624
April 26, 2018 [Member] | Convertible Notes Payable [Member]
Debt amount converted	$ 18,904
Number of shares issued upon conversion of debt	343,709
March 21, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 12,784
Number of shares issued upon conversion of debt		102,168
March 30, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 21,346
Number of shares issued upon conversion of debt		170,595
April 7, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 10,690
Number of shares issued upon conversion of debt		92,558
April 20, 2017 [Member] | Convertible Notes Payable [Member]
Debt amount converted		$ 35,372
Number of shares issued upon conversion of debt		321,567